Mutant p53 expression in fallopian tube epithelium drives cell migration

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• High-grade serous ovarian cancer (HGSC) is a leading cause of cancer death in US women.
• Evidence suggests HGSC may originate in the fallopian tube.
• The p53 pathway is frequently altered in HGSC, with the R273H mutation being common.

Purpose of the Study:

• To investigate the cellular and molecular effects of the p53 R273H mutation in potential progenitor cells of HGSC.
• To determine if p53 mutation alone is sufficient for cellular transformation.
• To explore tissue-specific effects of p53 mutation in ovarian and fallopian tube epithelial cells.

Main Methods:

• Stable transfection of murine oviductal epithelial cells (MOE) and murine ovarian surface epithelial cells (MOSE) with p53 R273H.
• Cell migration assays.
• Microarray analysis to assess gene expression changes.
• Xenografting of transformed cells into nude mice.

Main Results:

• p53 R273H mutation increased migration in MOE cells but not MOSE cells, indicating tissue-specific effects.
• Microarray data revealed altered expression of pro-migratory genes in p53 R273H MOE cells, which could be reversed by suppressing Slug.
• Combined p53 R273H and KRAS G12V activation led to high-grade sarcomatoid carcinoma in xenografts.

Conclusions:

• The p53 R273H mutation promotes cell migration in fallopian tube epithelial cells, a key step in early tumorigenesis.
• Tissue-specific effects of p53 mutations are crucial in HGSC development.
• Understanding p53's role can inform strategies to prevent HGSC progression and improve survival rates.